
The researchers from the University of Massachusetts Medical School (UMMS) in the US discovered and characterised a cross-reactive human monoclonal antibody (MAB) to SARS-CoV-2 spike proteins which blocks ACE2 receptor binding on the mucosal tissue of the respiratory tract.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3gqTu0o
via
IFTTT
0 comments:
Post a Comment